Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Opioid-Induced Hyperalgesia in Methadone-Maintained Patients
NCT01210079Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Sep 2002
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid-induced hyperalgesia (OIH) comparing Gabapentin with Placebo (2 arms). Primary endpoint: Change in Pain Threshold Time at 5 weeks. Started Sep 2002; status: completed.
02
Drugs
gabapentin
03
Conditions
opioid-induced hyperalgesia (OIH)
Beyond the preview
Go deeper on NCT01210079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210079.